Cargando…
Cure of Progressive Murine Leishmaniasis: Interleukin 4 Dominance Is Abolished by Transient CD4(+) T Cell Depletion and T Helper Cell Type 1–selective Cytokine Therapy
Progressive infection with Leishmania major in susceptible BALB/c mice is mediated by interleukin (IL)-4–producing T helper cell type 2 (Th2) CD4(+) T cells that, once established, become resistant to Th1-deviating therapies with recombinant (r)IL-12 and/or neutralizing anti–IL-4 antibodies. We soug...
Autores principales: | Heinzel, Frederick P., Rerko, Ronald M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192969/ https://www.ncbi.nlm.nih.gov/pubmed/10377185 |
Ejemplares similares
-
Transient CD4-cell-depletion therapy for HIV/AIDS cure
por: Wei, Min, et al.
Publicado: (2021) -
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets
Publicado: (1989) -
Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism
Publicado: (1990) -
Impaired Interleukin 4 Signaling in T Helper Type 1 Cells
por: Huang, Hua, et al.
Publicado: (1998) -
Oxazolone Colitis: A Murine Model of T Helper Cell Type 2 Colitis Treatable with Antibodies to Interleukin 4
por: Boirivant, Monica, et al.
Publicado: (1998)